Want To Stay Up-To-Date On The Latest 340B News?
"*" indicates required fields
Posted on July 6, 2018 |
“President Donald Trump in May said that drugmakers would soon announce “massive” price cuts, and his administration rolled out a plan to bring down the cost of medicines. But the companies don’t appear to have gotten that message.
Bayer raised the price of two cancer drugs by hundreds of dollars in May and Novartis followed by boosting four pricey treatments in June. Pfizer, one of the largest U.S. pharmaceutical companies, announced increases on more than 41 products this week. They weren’t alone.”
Read more: https://www.politico.com/story/2018/07/03/drugmakers-trump-drug-prices-668260